Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution
Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution
Status: Enrolling
Updated:  4/18/2013
Alcon Call Center
mi
from
Fort Worth, TX
Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution
Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution
Status: Enrolling
Updated: 4/18/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy of Changing to Travatan From Prior Therapy
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status: Enrolling
Updated:  4/22/2013
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy of Changing to Travatan From Prior Therapy
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status: Enrolling
Updated: 4/22/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses
Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection
Status: Enrolling
Updated:  4/22/2013
Alcon Call Center
mi
from
Fort Worth, TX
Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses
Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection
Status: Enrolling
Updated: 4/22/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Clinical Investigation of Expanded Designs of a Multifocal IOL
Clinical Investigation of Expanded Designs of the Tecnis® Multifocal 1-Piece IOL
Status: Enrolling
Updated:  4/25/2013
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Clinical Investigation of Expanded Designs of a Multifocal IOL
Clinical Investigation of Expanded Designs of the Tecnis® Multifocal 1-Piece IOL
Status: Enrolling
Updated: 4/25/2013
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
A Phase 1/2, First-in-Human, Double-Masked, Placebo-Controlled, Dose-Escalation Study Evaluating the Safety, Tolerability, and Efficacy of RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
Status: Enrolling
Updated:  4/26/2013
Virginia Eye Consultants
mi
from
Norfolk, VA
A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
A Phase 1/2, First-in-Human, Double-Masked, Placebo-Controlled, Dose-Escalation Study Evaluating the Safety, Tolerability, and Efficacy of RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
Status: Enrolling
Updated: 4/26/2013
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety Study of FID 119515A
A Randomized, Observer-Masked, Efficacy and Safety Study of FID 119515A in Dry Eye
Status: Enrolling
Updated:  5/3/2013
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
mi
from
Fort Worth, TX
Efficacy and Safety Study of FID 119515A
A Randomized, Observer-Masked, Efficacy and Safety Study of FID 119515A in Dry Eye
Status: Enrolling
Updated: 5/3/2013
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Tuscon, AZ
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Tuscon, AZ
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Torrance, CA
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Danbury, CT
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Danbury, CT
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Fort Myers, FL
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Pensacola, FL
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis
mi
from
Baltimore, MD
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Edina, MN
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Edina, MN
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
West Columbia, SC
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
West Columbia, SC
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Abilene, TX
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Abilene, TX
Click here to add this to my saved trials
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated:  5/9/2013
Novartis Investigative Site
mi
from
Forth Worth, TX
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration
Status: Enrolling
Updated: 5/9/2013
Novartis Investigative Site
mi
from
Forth Worth, TX
Click here to add this to my saved trials
Systane Balance - Inflammatory Markers
Study to Evaluate the Efficacy of Systane Balance in Reducing Symptoms and Inflammatory Biomarker Expression of HLA-DR and Tear Film Cytokines in Dry Eye Subjects With Lipid Deficiency
Status: Enrolling
Updated:  5/9/2013
Alcon Call Center
mi
from
Fort Worth, TX
Systane Balance - Inflammatory Markers
Study to Evaluate the Efficacy of Systane Balance in Reducing Symptoms and Inflammatory Biomarker Expression of HLA-DR and Tear Film Cytokines in Dry Eye Subjects With Lipid Deficiency
Status: Enrolling
Updated: 5/9/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Status: Enrolling
Updated:  5/14/2013
Bausch & Lomb Incorporated
mi
from
Rochester, NY
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
The Efficacy and Safety of Mapracorat Ophthalmic Suspension, 3% in Subjects for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Status: Enrolling
Updated: 5/14/2013
Bausch & Lomb Incorporated
mi
from
Rochester, NY
Click here to add this to my saved trials
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
Status: Enrolling
Updated:  5/15/2013
Havener Eye Institute
mi
from
Columbus, OH
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
Status: Enrolling
Updated: 5/15/2013
Havener Eye Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
Status: Enrolling
Updated:  5/15/2013
OSU College of Optometry
mi
from
Columbus, OH
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
Status: Enrolling
Updated: 5/15/2013
OSU College of Optometry
mi
from
Columbus, OH
Click here to add this to my saved trials
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/6/2013
Clinical Research Facility
mi
from
Decatur, GA
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/6/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/6/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/6/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/6/2013
Clinical Research Facility
mi
from
New York, NY
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/6/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/6/2013
Clinical Research Facility
mi
from
Cleveland, OH
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/6/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/6/2013
Clinical Research Facility
mi
from
Dallas, TX
Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
A Phase II, Randomized, Observer-masked, Placebo-and Active-controlled, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost and Placebo in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/6/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Arizona Eye Center
mi
from
Chandler, AZ
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Arizona Eye Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Cornea Consultants of Arizona
mi
from
Phoenix, AZ
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Cornea Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Eye Research Foundation
mi
from
Newport Beach, CA
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Eye Research Foundation
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
West Coast Eye Care Associates
mi
from
San Diego, CA
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
West Coast Eye Care Associates
mi
from
San Diego, CA
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Andrew Gardner Logan dba Logan Ophthalmic Research, LLC
mi
from
Tamarac, FL
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Andrew Gardner Logan dba Logan Ophthalmic Research, LLC
mi
from
Tamarac, FL
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Great Lakes Eye Care
mi
from
St. Joseph, MI
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Great Lakes Eye Care
mi
from
St. Joseph, MI
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Tauber Eye Center
mi
from
Kansas City, MO
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Tauber Eye Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Tekwani Vision Center
mi
from
St. Louis, MO
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Tekwani Vision Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Ophthalmology Associates
mi
from
St. Louis, MO
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Ophthalmology Associates
mi
from
St. Louis, MO
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Cornerstone Health Care
mi
from
High Point, NC
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Cornerstone Health Care
mi
from
High Point, NC
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
James D. Branch, MD
mi
from
Winston-Salem, NC
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
James D. Branch, MD
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
Total Eye Care,P.A
mi
from
Memphis, TN
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
Total Eye Care,P.A
mi
from
Memphis, TN
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
David G. Shulman, MD
mi
from
San Antonio, TX
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
David G. Shulman, MD
mi
from
San Antonio, TX
Click here to add this to my saved trials
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated:  6/13/2013
DCT Kumar, LLc dba Discovery Clinical Trials
mi
from
Uvalde, TX
Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
A Randomized Double-Masked Study to Compare the Ocular Safety,Tolerability,and Efficacy of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects
Status: Enrolling
Updated: 6/13/2013
DCT Kumar, LLc dba Discovery Clinical Trials
mi
from
Uvalde, TX
Click here to add this to my saved trials
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Status: Enrolling
Updated:  6/15/2013
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Status: Enrolling
Updated: 6/15/2013
Northern California Retina Vitreous Associates
mi
from
Mountain View, CA
Click here to add this to my saved trials
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Status: Enrolling
Updated:  6/18/2013
Northeastern State University
mi
from
Tahlequah, OK
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
Status: Enrolling
Updated: 6/18/2013
Northeastern State University
mi
from
Tahlequah, OK
Click here to add this to my saved trials
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
An Open-Label Study to Evaluate the Effects of Repeated Treatments of Oral QLT091001 on Safety and Vision Outcome in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT) (Extension of Study RET IRD 01)
Status: Enrolling
Updated:  6/19/2013
The Chicago Lighthouse (University of Illinois at Chicago, Pangere Center for Inherited Retinal Disease)
mi
from
Chicago, IL
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
An Open-Label Study to Evaluate the Effects of Repeated Treatments of Oral QLT091001 on Safety and Vision Outcome in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT) (Extension of Study RET IRD 01)
Status: Enrolling
Updated: 6/19/2013
The Chicago Lighthouse (University of Illinois at Chicago, Pangere Center for Inherited Retinal Disease)
mi
from
Chicago, IL
Click here to add this to my saved trials
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
An Open-Label Study to Evaluate the Effects of Repeated Treatments of Oral QLT091001 on Safety and Vision Outcome in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT) (Extension of Study RET IRD 01)
Status: Enrolling
Updated:  6/19/2013
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
An Open-Label Study to Evaluate the Effects of Repeated Treatments of Oral QLT091001 on Safety and Vision Outcome in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT) (Extension of Study RET IRD 01)
Status: Enrolling
Updated: 6/19/2013
Wilmer Eye Institute, Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated:  6/28/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
Status: Enrolling
Updated: 6/28/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Flare Photometry in Uveitis Patients
Status: Enrolling
Updated:  7/10/2013
UW Medicine Eye Institute
mi
from
Seattle, WA
Flare Photometry in Uveitis Patients
Status: Enrolling
Updated: 7/10/2013
UW Medicine Eye Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Prior Prostaglandin Fixed Combination
Status: Enrolling
Updated:  7/18/2013
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Assessing the Efficacy and Tolerability of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination), as Replacement Therapy in Patients Previously on Prior Prostaglandin Fixed Combination
Status: Enrolling
Updated: 7/18/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad® Preservative (Travoprost 0.004%) Versus LUMIGAN® 0.01% Solution With BAK (Bimatoprost 0.01%) in Treatment Naïve Patients With Ocular Hypertension or Open Angle Glaucoma
Status: Enrolling
Updated:  7/18/2013
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
mi
from
Fort Worth, TX
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad® Preservative (Travoprost 0.004%) Versus LUMIGAN® 0.01% Solution With BAK (Bimatoprost 0.01%) in Treatment Naïve Patients With Ocular Hypertension or Open Angle Glaucoma
Status: Enrolling
Updated: 7/18/2013
Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials